Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors.

PubWeight™: 2.22‹?› | Rank: Top 2%

🔗 View Article (PMID 9000102)

Published in J Gen Virol on December 01, 1996

Authors

M Mendelson1, S Monard, P Sissons, J Sinclair

Author Affiliations

1: Department of Medicine, University of Cambridge, Addenbrooke's Hospital, UK.

Articles citing this

Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol (2003) 3.97

Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci U S A (1998) 3.12

Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev (2012) 2.92

Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev (2009) 2.75

Cytomegalovirus encodes a potent alpha chemokine. Proc Natl Acad Sci U S A (1999) 2.51

Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci U S A (2005) 2.34

Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency. Proc Natl Acad Sci U S A (2002) 2.15

Quantitative analysis of latent human cytomegalovirus. J Virol (1999) 2.11

Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells. Proc Natl Acad Sci U S A (2003) 2.05

Consensus on the role of human cytomegalovirus in glioblastoma. Neuro Oncol (2012) 2.02

Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro. Blood (2007) 1.73

Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence. J Virol (2004) 1.66

Cellular localization of latent murine cytomegalovirus. J Virol (1998) 1.62

Human cytomegalovirus gene expression is silenced by Daxx-mediated intrinsic immune defense in model latent infections established in vitro. J Virol (2007) 1.60

Focal transcriptional activity of murine cytomegalovirus during latency in the lungs. J Virol (1999) 1.59

A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. J Virol (2004) 1.57

The human cytomegalovirus major immediate-early distal enhancer region is required for efficient viral replication and immediate-early gene expression. J Virol (2000) 1.45

Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J Virol (2003) 1.44

Reactivation of the human cytomegalovirus major immediate-early regulatory region and viral replication in embryonal NTera2 cells: role of trichostatin A, retinoic acid, and deletion of the 21-base-pair repeats and modulator. J Virol (2001) 1.42

Replication of murine cytomegalovirus in differentiated macrophages as a determinant of viral pathogenesis. J Virol (1999) 1.42

Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: a model for reactivation from latency. J Virol (2001) 1.35

Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus. J Virol (2005) 1.32

Characterization of a novel Golgi apparatus-localized latency determinant encoded by human cytomegalovirus. J Virol (2009) 1.29

Cellular and viral control over the initial events of human cytomegalovirus experimental latency in CD34+ cells. J Virol (2010) 1.29

Cytomegalovirus-induced immunopathology and its clinical consequences. Herpesviridae (2011) 1.19

Viral effects on metabolism: changes in glucose and glutamine utilization during human cytomegalovirus infection. Trends Microbiol (2011) 1.17

Sustained CD8+ T cell memory inflation after infection with a single-cycle cytomegalovirus. PLoS Pathog (2011) 1.16

Random, asynchronous, and asymmetric transcriptional activity of enhancer-flanking major immediate-early genes ie1/3 and ie2 during murine cytomegalovirus latency in the lungs. J Virol (2001) 1.16

Human cytomegalovirus 5-kilobase immediate-early RNA is a stable intron. J Virol (2004) 1.15

The human cytomegalovirus UL82 gene product (pp71) accelerates progression through the G1 phase of the cell cycle. J Virol (2003) 1.14

Cis and trans acting factors involved in human cytomegalovirus experimental and natural latent infection of CD14 (+) monocytes and CD34 (+) cells. PLoS Pathog (2013) 1.12

Inhibition of inflammatory interleukin-6 activity via extracellular signal-regulated kinase-mitogen-activated protein kinase signaling antagonizes human cytomegalovirus reactivation from dendritic cells. J Virol (2011) 1.08

Human cytomegalovirus latency-associated protein pORF94 is dispensable for productive and latent infection. J Virol (2000) 1.07

Human cytomegalovirus reactivation during lactation and mother-to-child transmission in preterm infants. J Clin Microbiol (2005) 1.06

Viral interleukin-10 expressed by human cytomegalovirus during the latent phase of infection modulates latently infected myeloid cell differentiation. J Virol (2011) 1.06

The myeloid transcription factor GATA-2 regulates the viral UL144 gene during human cytomegalovirus latency in an isolate-specific manner. J Virol (2013) 1.06

Inhibition of CD1 antigen presentation by human cytomegalovirus. J Virol (2008) 1.02

Efficient human cytomegalovirus reactivation is maturation dependent in the Langerhans dendritic cell lineage and can be studied using a CD14+ experimental latency model. J Virol (2012) 0.99

Human cytomegalovirus latency-associated proteins elicit immune-suppressive IL-10 producing CD4⁺ T cells. PLoS Pathog (2013) 0.99

Tegument protein control of latent herpesvirus establishment and animation. Herpesviridae (2011) 0.98

The human cytomegalovirus UL36 gene controls caspase-dependent and -independent cell death programs activated by infection of monocytes differentiating to macrophages. J Virol (2010) 0.97

Impact of human cytomegalovirus latent infection on myeloid progenitor cell gene expression. J Virol (2004) 0.97

Chromatin-mediated regulation of cytomegalovirus gene expression. Virus Res (2010) 0.97

Murine cytomegalovirus major immediate-early protein 3 interacts with cellular and viral proteins in viral DNA replication compartments and is important for early gene activation. J Gen Virol (2010) 0.96

Enhanced cytomegalovirus infection in atherosclerotic human blood vessels. Am J Pathol (2004) 0.95

Human cytomegalovirus IE1 protein elicits a type II interferon-like host cell response that depends on activated STAT1 but not interferon-γ. PLoS Pathog (2011) 0.95

The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies? Cell Mol Immunol (2014) 0.95

Tale of a tegument transactivator: the past, present and future of human CMV pp71. Future Virol (2012) 0.94

Circulating dendritic cells isolated from healthy seropositive donors are sites of human cytomegalovirus reactivation in vivo. J Virol (2013) 0.91

Hematopoietic stem cells and retroviral infection. Retrovirology (2010) 0.91

Human cytomegalovirus inhibits cytokine-induced macrophage differentiation. J Virol (2004) 0.90

Myeloblastic cell lines mimic some but not all aspects of human cytomegalovirus experimental latency defined in primary CD34+ cell populations. J Virol (2013) 0.89

Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro. J Virol (2014) 0.88

Contribution of the Major ND10 Proteins PML, hDaxx and Sp100 to the Regulation of Human Cytomegalovirus Latency and Lytic Replication in the Monocytic Cell Line THP-1. Viruses (2015) 0.87

Phorbol ester-induced human cytomegalovirus major immediate-early (MIE) enhancer activation through PKC-delta, CREB, and NF-kappaB desilences MIE gene expression in quiescently infected human pluripotent NTera2 cells. J Virol (2010) 0.87

Human Cytomegalovirus Latency: Approaching the Gordian Knot. Annu Rev Virol (2016) 0.86

The intimate relationship between human cytomegalovirus and the dendritic cell lineage. Front Microbiol (2014) 0.85

Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis. Infect Disord Drug Targets (2011) 0.85

Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology. Virulence (2012) 0.84

CD8+ T-cell recognition of human cytomegalovirus latency-associated determinant pUL138. J Gen Virol (2010) 0.84

Wnt modulating agents inhibit human cytomegalovirus replication. Antimicrob Agents Chemother (2013) 0.84

BH3 Profiling Reveals Selectivity by Herpesviruses for Specific Bcl-2 Proteins To Mediate Survival of Latently Infected Cells. J Virol (2015) 0.84

A short cis-acting motif in the M112-113 promoter region is essential for IE3 to activate M112-113 gene expression and is important for murine cytomegalovirus replication. J Virol (2012) 0.83

Release of human cytomegalovirus from latency by a KAP1/TRIM28 phosphorylation switch. Elife (2015) 0.83

Regulation of human cytomegalovirus transcription in latency: beyond the major immediate-early promoter. Viruses (2013) 0.83

Hematopoietic stem cell transplantation with latently infected donors does not transmit virus to immunocompromised recipients in the murine model of cytomegalovirus infection. Med Microbiol Immunol (2008) 0.82

Mitogen and stress activated kinases act co-operatively with CREB during the induction of human cytomegalovirus immediate-early gene expression from latency. PLoS Pathog (2014) 0.82

Repression of human cytomegalovirus major immediate early gene expression by the cellular transcription factor CCAAT displacement protein. Virology (2008) 0.82

Human cytomegalovirus manipulation of latently infected cells. Viruses (2013) 0.81

Using the nonhuman primate model of HCMV to guide vaccine development. Viruses (2014) 0.81

Cytomegalovirus infection in pediatric rheumatic diseases: a review. Pediatr Rheumatol Online J (2010) 0.81

The human eye (retina): a site of persistent HCMV infection? Graefes Arch Clin Exp Ophthalmol (2005) 0.81

Persisting murine cytomegalovirus can reactivate and has unique transcriptional activity in ocular tissue. J Virol (2002) 0.80

Glucocorticosteroids trigger reactivation of human cytomegalovirus from latently infected myeloid cells and increase the risk for HCMV infection in D+R+ liver transplant patients. J Gen Virol (2014) 0.80

Human cytomegalovirus tropism for mucosal myeloid dendritic cells. Rev Med Virol (2014) 0.80

Inhibition of the FACT Complex Reduces Transcription from the Human Cytomegalovirus Major Immediate Early Promoter in Models of Lytic and Latent Replication. J Virol (2016) 0.79

Human Cytomegalovirus US28 Is Important for Latent Infection of Hematopoietic Progenitor Cells. J Virol (2015) 0.79

Functional annotation of human cytomegalovirus gene products: an update. Front Microbiol (2014) 0.79

Dynamics of Human Cytomegalovirus Infection in CD34+ Hematopoietic Cells and Derived Langerhans-Type Dendritic Cells. J Virol (2015) 0.78

Perivascular stromal cells as a potential reservoir of human cytomegalovirus. Am J Transplant (2014) 0.78

Spontaneous resolution of intravitreal steroid-induced bilateral cytomegalovirus retinitis. Korean J Ophthalmol (2012) 0.77

Virus reactivation: a panoramic view in human infections. Future Virol (2011) 0.76

HCMV requires EGFR signaling to enter and initiate the early steps in the establishment of latency in CD34+ human progenitor cells. J Virol (2016) 0.76

Human cytomegalovirus plasmid-based amplicon vector system for gene therapy. Genet Vaccines Ther (2005) 0.75

Activation of Langerhans-Type Dendritic Cells Alters Human Cytomegalovirus Infection and Reactivation in a Stimulus-Dependent Manner. Front Microbiol (2016) 0.75

Exploiting viral natural history for vaccine development. Med Microbiol Immunol (2015) 0.75

Mechanisms modulating immune clearance during human cytomegalovirus latency. Proc Natl Acad Sci U S A (2012) 0.75

Human Cytomegalovirus miR-UL148D Facilitates Latent Viral Infection by Targeting Host Cell Immediate Early Response Gene 5. PLoS Pathog (2016) 0.75

Enhanced Induction of T Cell Immunity Using Dendritic Cells Pulsed with HIV Tat and HCMV-pp65 Fusion Protein In Vitro. Immune Netw (2011) 0.75

Intratumoral infection by CMV may change the tumor environment by directly interacting with tumor-associated macrophages to promote cancer immunity. Hum Vaccin Immunother (2017) 0.75

Human Cytomegalovirus-Induced Degradation of CYTIP Modulates Dendritic Cell Adhesion and Migration. Front Immunol (2017) 0.75

Articles by these authors

Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science (1998) 12.05

Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J Exp Med (1993) 5.40

Early haemo-diafiltration in meningococcal septicaemia. Lancet (1996) 5.35

Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J Virol (1999) 3.79

Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. Science (1998) 3.39

Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivo. Nat Med (2001) 3.33

The human cytomegalovirus 80-kilodalton but not the 72-kilodalton immediate-early protein transactivates heterologous promoters in a TATA box-dependent mechanism and interacts directly with TFIID. J Virol (1992) 3.28

Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors. J Virol (2000) 3.18

Ribosomal RNA genes and plant development. Nature (1972) 2.76

Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses. J Exp Med (1988) 2.73

Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J Virol (1994) 2.68

Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein. EMBO J (1994) 2.25

Isolation of deoxyribonucleic acid from mitochondria of chick embryo heart and liver. Proc Natl Acad Sci U S A (1965) 2.24

The human cytomegalovirus 86K immediate early (IE) 2 protein requires the basic region of the TATA-box binding protein (TBP) for binding, and interacts with TBP and transcription factor TFIIB via regions of IE2 required for transcriptional regulation. J Gen Virol (1993) 2.03

Medical staffing in Ontario neonatal intensive care units. CMAJ (1989) 1.97

Species distribution and properties of nuclear satellite DNA in higher plants. Nat New Biol (1973) 1.68

Latent and persistent infections of monocytes and macrophages. Intervirology (1996) 1.61

Importation of dogs into the United States: risks from rabies and other zoonotic diseases. Zoonoses Public Health (2008) 1.57

ASCIA guidelines for prevention of food anaphylactic reactions in schools, preschools and child-care centres. J Paediatr Child Health (2004) 1.53

Natural infection of a homozygous delta24 CCR5 red-capped mangabey with an R2b-tropic simian immunodeficiency virus. J Exp Med (1998) 1.50

The Relationship between Satellite Deoxyribonucleic Acid, Ribosomal Ribonucleic Acid Gene Redundancy, and Genome Size in Plants. Plant Physiol (1975) 1.42

Child physical abuse observed. Comparison of families with and without history of child abuse treated in an in-patient family unit. Br J Psychiatry (1991) 1.41

Aspects of human cytomegalovirus latency and reactivation. Curr Top Microbiol Immunol (2008) 1.38

Expression patterns of the HIV type 1 coreceptors CCR5 and CXCR4 on CD4+ T cells and monocytes from cord and adult blood. AIDS Res Hum Retroviruses (1998) 1.33

A comparison of high and low fat meals on postprandial esophageal acid exposure. Am J Gastroenterol (1989) 1.28

Urology in a modern health centre. Br Med J (1975) 1.26

Users' guides to the medical literature: XVI. How to use a treatment recommendation. Evidence-Based Medicine Working Group and the Cochrane Applicability Methods Working Group. JAMA (1999) 1.23

c-erbB-2 oncoprotein expression in mammary and extramammary Paget's disease: an immunohistochemical study. Histopathology (1990) 1.22

Virologic and immunologic effect of antiretroviral therapy on HIV-1 in gut-associated lymphoid tissue. J Acquir Immune Defic Syndr (2001) 1.22

Frequency of hepatitis B antigen in blood donors. Can Med Assoc J (1973) 1.19

In situ detection of neuronal DNA strand breaks using the Klenow fragment of DNA polymerase I reveals different mechanisms of neuron death after global cerebral ischemia. J Neurochem (1999) 1.13

Astroglia and glutamate in physiology and pathology: aspects on glutamate transport, glutamate-induced cell swelling and gap-junction communication. Neurochem Int (2000) 1.10

Eubacterial arylamine N-acetyltransferases - identification and comparison of 18 members of the protein family with conserved active site cysteine, histidine and aspartate residues. Microbiology (2001) 1.09

Human cytomegalovirus immediate-early 2 (IE2) protein can transactivate the human hsp70 promoter by alleviation of Dr1-mediated repression. J Virol (1996) 1.06

Gastroesophageal reflux induced by exercise in healthy volunteers. JAMA (1989) 1.03

Randomized controlled trial of the Alexander technique for idiopathic Parkinson's disease. Clin Rehabil (2002) 1.03

Vertebral artery dissection with a normal-appearing lumen at multisection CT angiography: the importance of identifying wall hematoma. AJNR Am J Neuroradiol (2009) 1.02

Three-dimensional in vitro cell biology models of ovarian and endometrial cancer. Cell Prolif (2009) 1.02

Temperature quantitation and mapping of frozen tissue. J Magn Reson Imaging (2001) 0.99

Human immunodeficiency virus type 1- and cytomegalovirus-specific cytotoxic T lymphocytes can persist at high frequency for prolonged periods in the absence of circulating peripheral CD4(+) T cells. J Virol (2000) 0.97

Immunoaffinity purification of a 72K early antigen of human cytomegalovirus: analysis of humoral and cell-mediated immunity to the purified polypeptide. J Gen Virol (1987) 0.97

Studies on a thermal reaction associated with photosynthetic oxygen evolution. Biochim Biophys Acta (1974) 0.96

Radiologic and postmortem survey of abdominal lesions. With special reference to lesions of urinary tract. Urology (1974) 0.95

The complexity of satellite deoxyribonucleic acid in a higher plant. Biochem J (1975) 0.94

A backflow of electrons around photosystem II in Chlorella cells. Biochim Biophys Acta (1979) 0.93

A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures. Br J Cancer (2011) 0.92

Nuclear and cytoplasmic dynamics of sperm penetration, pronuclear formation and microtubule organization during fertilization and early preimplantation development in the human. Hum Reprod Update (1995) 0.91

Trial of aspirin and RA 233 in prevention of post-operative deep vein thrombosis. Thromb Diath Haemorrh (1973) 0.90

Mitochondrial transfer between oocytes: potential applications of mitochondrial donation and the issue of heteroplasmy. Hum Reprod (1998) 0.90

Construction of cosmid libraries from flow-sorted human chromosomes 1, 6, 7, 11, 13, and 18 for reference library resources. Mamm Genome (1994) 0.89

Evidence for cytochrome P450-mediated oxidation of uroporphyrinogen by cell-free liver extracts from chick embryos treated with 3-methylcholanthrene. Biochem Biophys Res Commun (1987) 0.89

Cell-specific and efficient expression in mouse and human B cells by a novel hybrid immunoglobulin promoter in a lentiviral vector. Gene Ther (2007) 0.88

TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2. AIDS (1997) 0.88

Alcohol use can result in enhanced drug metabolism in HIV pharmacotherapy. AIDS Patient Care STDS (2001) 0.85

Studies on the rate-limiting reaction of photosynthetic oxygen evolution in spinach chloroplasts. Biochim Biophys Acta (1976) 0.83

Increased risk of adverse events when changing intravenous immunoglobulin preparations. Clin Exp Immunol (2004) 0.83

Alginic acid decreases postprandial upright gastroesophageal reflux. Comparison with equal-strength antacid. Dig Dis Sci (1992) 0.83

Analysis of the human env-specific cytotoxic T-lymphocyte (CTL) response in natural human immunodeficiency virus type 1 infection: low prevalence of broadly cross-reactive env-specific CTL. J Virol (1996) 0.83

Fluorescent in situ identification of human marker chromosomes using flow sorting and Alu element-mediated PCR. Genomics (1992) 0.82

Isolation of rat chromosome-specific paint probes by bivariate flow sorting followed by degenerate oligonucleotide primed-PCR. Cytogenet Cell Genet (1994) 0.82

Diagnostic accuracy of dynamic contrast-enhanced MR imaging using a phase-derived vascular input function in the preoperative grading of gliomas. AJNR Am J Neuroradiol (2012) 0.82

Urokinase: a treatment for relapsing peritonitis due to coagulase-negative staphylococci. Nephrol Dial Transplant (1989) 0.82

Infection and reactivation with cytomegalovirus strains in lung transplant recipients. Transplantation (1991) 0.82

Changes in ventilation related to changes in electromyograph activity during repetitive bouts of isometric exercise in simulated sailing. Eur J Appl Physiol Occup Physiol (1996) 0.82

The clinical features of paediatric meningococcal disease Auckland, 1985-87. N Z Med J (1989) 0.82

Reporting of post-transfusion jaundice. Can Med Assoc J (1973) 0.81

Relationship between seizure-induced transcription of the DNA damage-inducible gene GADD45, DNA fragmentation, and neuronal death in focally evoked limbic epilepsy. J Neurochem (1999) 0.81

Treatment of diabetic gastroparesis with oral domperidone. Diabet Med (1985) 0.81

Fluorescence in situ hybridisation studies to characterise complete and partial monosomy 7 in myeloid disorders. Genes Chromosomes Cancer (1994) 0.80

Advanced age, but not anergy, is associated with altered serum polyunsaturated fatty acid levels. J Nutr Health Aging (2003) 0.79

Signal-transduction pathways involved in the hypertrophic effect of hsp56 in neonatal cardiomyocytes. J Mol Cell Cardiol (2004) 0.79

Immunochemical detection of different isoenzymes of cytochrome P-450 induced in chick hepatocyte cultures. Biochem J (1989) 0.79

An outbreak of meningococcal disease in Auckland, New Zealand. Pediatr Infect Dis J (1989) 0.78

Spatio-temporal profile of DNA fragmentation and its relationship to patterns of epileptiform activity following focally evoked limbic seizures. Brain Res (2000) 0.78

The incidence of deep vein thrombosis in prostatectomised patients following the administration of the fibrinolytic inhibitor, aminocaproic acid (EACA). Urol Res (1976) 0.78

The t(14;18) in a patient with de novo acute lymphoblastic leukemia is associated with t(8;9). Leukemia (1994) 0.78

Expert system diagnosis of ichthyosis. Clin Exp Dermatol (1987) 0.77

The effects of the hole in the ozone layer on health. Nurs Stand (2000) 0.76

Activation of beta-adrenoceptors opens calcium-activated potassium channels in astroglial cells. Neurochem Int (2001) 0.76

Alcoholic beverages in acute porphyria. J Stud Alcohol (1992) 0.76

Induction of cytochrome P-450 by alcohols and 4-substituted pyrazoles. Comparison of structure-activity relationships. Biochem Pharmacol (1986) 0.76

Histological and ultrastructural changes in rat kidney following cadmium injection. Urol Res (1977) 0.75

The results of 100 small tissue biopsies of testis in male infertile patients. Postgrad Med J (1976) 0.75

Bloodless circumcision. BJU Int (1999) 0.75

Urokinase for recurrent CAPD peritonitis. Lancet (1987) 0.75

Factors influencing in vitro production of colony-stimulating factor by mononuclear leukocytes from humans. Can Med Assoc J (1979) 0.75

The cost effectiveness of radon reduction programmes in domestic housing in England and Wales: the impact of improved radon mapping and housing trends. Environ Int (2013) 0.75

Variations in photosynthetic electron-transport pathways in Chlorella vulgaris. Biochem Soc Trans (1978) 0.75

Practical experience of using the IPEM 2003 electron code of practice. Br J Radiol (2009) 0.75

A child with recurrent infections. Acta Paediatr (1998) 0.75

[Contraception by Depo Provera. Apropos of 61 cases]. Lille Med (1973) 0.75

[Vaginal contraception: mechanical or chemical?]. NPN Med (1983) 0.75

School girl to nurse 1960's. Nurs Prax N Z (1995) 0.75

Qualitative analysis of Coroners' data into the unnatural deaths of children and adolescents. Child Care Health Dev (2008) 0.75

Recurrent posterior shoulder dislocation in children: the results of surgical management. J Pediatr Orthop (1997) 0.75

Archibald (Arch) Niven Sinclair 1926-2016. Aust Vet J (2016) 0.75

Effect of arsenite on induction of CYP1A and CYP2H in primary cultures of chick hepatocytes. Toxicol Appl Pharmacol (1998) 0.75

[Toxoplasmosis in obstetrics departments]. Lille Med (1975) 0.75

[Evaluation of a contraception clinic in a university hospital department]. Lille Med (1973) 0.75